Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert Samstein(Icahn School of Medicine at Mount Sinai), Ronald P. DeMatteo(University of Pennsylvania), Emmet Jordan(Memorial Sloan Kettering Cancer Center), José Baselga(Novartis (Switzerland)), Lisa M. DeAngelis(Memorial Sloan Kettering Cancer Center), David G. Pfister(Memorial Sloan Kettering Cancer Center), Ahmet Zehir(Natera (United States)), Sviatoslav M. Kendall(Memorial Sloan Kettering Cancer Center), Chung‐Han Lee(Memorial Sloan Kettering Cancer Center), Yelena Y. Janjigian(Memorial Sloan Kettering Cancer Center), Ingo K. Mellinghoff(Memorial Sloan Kettering Cancer Center), Hikmat Al‐Ahmadie(Unknown), Christopher A. Barker(Cornell University), Pedram Razavi(Memorial Sloan Kettering Cancer Center), Matthew D. Hellmann(AstraZeneca (United States)), Paul Russo(Memorial Sloan Kettering Cancer Center), William D. Tap(Memorial Sloan Kettering Cancer Center), Antonio Omuro(Johns Hopkins University), Mrinal M. Gounder(Memorial Sloan Kettering Cancer Center), Alan L. Ho(Memorial Sloan Kettering Cancer Center), Leonard B. Saltz(Memorial Sloan Kettering Cancer Center), Rona Yaeger(Memorial Sloan Kettering Cancer Center), Alexander N. Shoushtari(Memorial Sloan Kettering Cancer Center), Thomas Kaley(Roswell Park Comprehensive Cancer Center), Charles M. Rudin(Memorial Sloan Kettering Cancer Center), Jonathan E. Rosenberg(Memorial Sloan Kettering Cancer Center), Nancy Y. Lee(Memorial Sloan Kettering Cancer Center), Jedd D. Wolchok(Cornell University), Ronglai Shen(Memorial Sloan Kettering Cancer Center), Robert J. Motzer(Memorial Sloan Kettering Cancer Center), Gregory J. Riely(Memorial Sloan Kettering Cancer Center), Philip H. Gutin(Memorial Sloan Kettering Cancer Center), Neil H. Segal(Kettering University), Gopa Iyer(Memorial Sloan Kettering Cancer Center), Dean F. Bajorin(Memorial Sloan Kettering Cancer Center), Geoffrey Y. Ku(Memorial Sloan Kettering Cancer Center), Howard I. Scher(Memorial Sloan Kettering Cancer Center), Zsofia K. Stadler(Memorial Sloan Kettering Cancer Center), Christopher A. Klebanoff(Cornell University), Richard J. Wong(Memorial Sloan Kettering Cancer Center), Viviane Tabar(Memorial Sloan Kettering Cancer Center), Bernard H. Bochner(Memorial Sloan Kettering Cancer Center), Cameron Brennan(Memorial Sloan Kettering Cancer Center), A. Ari Hakimi(Penn State Milton S. Hershey Medical Center), Sandra P. D’Angelo(Memorial Sloan Kettering Cancer Center), Jamie E. Chaft(Memorial Sloan Kettering Cancer Center), David Barron(Memorial Sloan Kettering Cancer Center), Shrujal S. Baxi(Cambridge Health Alliance), Martin H. Voss(Memorial Sloan Kettering Cancer Center), Charlotte E. Ariyan(Memorial Sloan Kettering Cancer Center)
Cited by 4,354
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
|New England Journal of Medicine|2018|4.6k